View Profile

SUJEET KUMAR

Professor-Pharmaceutical Chemistry/Pharmacy · Nitte College of Pharmaceutical Sciences (A constituent unit of Nitte Education Trust), Bengaluru

https://researchid.co/sujeet
@dr.sujeethkumar@nitte.edu.in
52Scopus Publications
1437Google Scholar Citations
16Google Scholar h-index
27Google Scholar i10-index

Research Interests

Biologically active small heterocyclic molecules.

Biography

I have been working with KLE College of Pharmacy Bangalore (India) since July 2007 in the Department of Pharmaceutical Chemistry (Associate Professor at present). During my master’s (Pharmaceutical Chemistry) and PhD, I worked on nitrogen, oxygen, and sulfur-containing biologically active small heterocyclic molecules. My Post-doctoral research in the Department of Biomaterials Science at the Pusan National University Republic of Korea gave me in-depth knowledge about the functionalization of biopolymers as a drug delivery tool. Multistep synthesis of heterocyclic molecules, their purification and, structural characterization is the area of my research. I believe in teamwork and collaborative research. In the 15 years of teaching & research, I contributed to 35 research articles. Pharmaceutics, Cell, FEBS, Scientific Reports, EJMC, BMCL, Molecular Carcinogenesis and RSC Advances are few among them

Education

PhD in Pharmaceutical Sciences (JNTU, Hyderabad)

Recent Scopus Publications

  1. Synthesis, In Vitro Cytotoxicity Evaluation and GSK-3β Binding Study of Some Indole–Triazole-Linked Pyrazolone Derivatives
    Chemistry Switzerland, 2026
  2. Functional Characterization of VS-186B, a Novel HDAC Inhibitor with Anticancer Activity
    International Journal of Molecular Sciences, 2025
  3. Andrographolide and Mahua Oil-Infused Emulgels: A Comprehensive QbD, In Vitro, and In Silico Strategy for Skin Pigmentation Treatment
    Chemistry and Biodiversity, 2025
  4. Impact of NaI/KI blending on structural, optical, and impedance properties of sodium carboxymethyl cellulose biopolymer films
    Polymer Bulletin, 2025
  5. Design, synthesis and anticancer evaluation of novel hydrazide-2-oxindole analogues as GSK-3β kinase inhibitors
    Rsc Advances, 2025

Research Outputs

Indian Patent filed (as co-inventor), Title: Novel inhibitors of anti-apoptotic BCL-2 Proteins. US Patent filed (as co-inventor), Title: Pyrazole derivatives with anticancer activity.

Grants / Consultancy

UGC sponsored project (Diary No.5739MRP(S)-0368/1314/ KABA023/UGCSWRO, dated 28-3-2014 (₹ 1,85,000.00). AICTE sponsored Research Promotion Scheme, F. No.

Links